Market revenue in 2023 | USD 10,224.6 million |
Market revenue in 2030 | USD 28,333.2 million |
Growth rate | 15.7% (CAGR from 2023 to 2030) |
Largest segment | Chromatography systems |
Fastest growing segment | Dryers |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Chromatography Systems, Filters, Evaporators, Centrifuges, Dryers |
Key market players worldwide | Merck KGaA, Sartorius AG, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Danaher Corp, Repligen Corp, 3M Co, Boehringer Ingelheim, Corning Inc, Lonza Group Ltd, Dover Corp, Asahi Kasei Corp, Eppendorf |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to downstream processing market will help companies and investors design strategic landscapes.
Chromatography systems was the largest segment with a revenue share of 41.75% in 2023. Horizon Databook has segmented the Asia Pacific downstream processing market based on chromatography systems, filters, evaporators, centrifuges, dryers covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to be the fastest growing region in the downstream processing market throughout the forecast period owing to continuous reforms in the healthcare and biotechnology industries in the region. In addition, large regional population and untapped potential present in the region have resulted into business shift of global firms in this region.
Moreover, this region offers relatively inexpensive manufacturing & operating unit for conducting research. Furthermore, it is estimated that the number of world’s new bioprocessing facilities are being developed by Asian local and international companies. Primary focus of the Asian entities is development of biosimilar monoclonal antibodies (mAbs) as well as vaccines through bioprocess technology.
Several global companies are making investments in this constantly growing bioprocessing regional market. For instance, in December 2014, Amgen’s USD 160 million manufacturing plant was established in Singapore, which uses bioprocessing technologies in 90% of its operations.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific downstream processing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific downstream processing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account